{"id":"NCT00524368","sponsor":"Tibotec Pharmaceuticals, Ireland","briefTitle":"A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)","officialTitle":"A Randomized, Open-label Trial to Compare the Efficacy, Safety and Tolerability of DRV/Rtv (800mg/100mg) q.d Versus DRV/Rtv (600mg/100mg) b.i.d in Early Treatment-experienced HIV-1 Infected Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2009-08","completion":"2011-10","firstPosted":"2007-09-03","resultsPosted":"2010-09-22","lastUpdate":"2013-02-15"},"enrollment":590,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Human Immunodeficiency Virus - Type 1"],"interventions":[{"type":"DRUG","name":"Darunavir (DRV)","otherNames":["TMC114"]},{"type":"DRUG","name":"Ritonavir (rtv)","otherNames":["rtv"]}],"arms":[{"label":"DRV/rtv 800/100 mg once daily","type":"EXPERIMENTAL"},{"label":"DRV/rtv 600/100 mg twice daily","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to test if being treated with darunavir/ritonavir (DRV/rtv) 800/100 mg daily is as effective as being treated with DRV/rtv 600/100 mg twice daily, in early antiretroviral (ARV)-experienced patients when given along with selected optimized background regimen (OBR).","primaryOutcome":{"measure":"Virological Response at Week 48 (Number of Participants With Plasma Viral Load Less Than 50 Copies/mL) - as Defined by the Time to Loss of Virologic Response (TLOVR) Algorithm","timeFrame":"48 Weeks","effectByArm":[{"arm":"DRV/Rtv 800/100 mg Once Daily","deltaMin":212,"sd":null},{"arm":"DRV/Rtv 600/100 mg Twice Daily","deltaMin":210,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":85,"countries":["United States","Argentina","Australia","Austria","Brazil","Chile","France","Germany","Guatemala","Hungary","Malaysia","Panama","Puerto Rico","Romania","South Africa","Spain","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["23558157"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":294},"commonTop":["Diarrhoea","Nausea","Headache","Vomiting","Nasopharyngitis"]}}